(NSE:SUNPHARMA) Inverted H&S Breakout Eyes New ATH Chart Analysis:
Sun Pharma has formed a textbook Inverted Head & Shoulders (H&S) pattern on the daily timeframe, signaling a strong bullish reversal. The pattern completed with a clean breakout above the neckline at ₹1,820 , accompanied by a surge in trading volume (highest in 2 weeks). This validates buyer conviction and sets the stage for a sustained upward move.
Key Levels:
Neckline: ₹1,820
Resistance Targets:
Target 1: ₹1,910
Target 2: ₹1,960 (All-Time High, ATH)
Support Zone:1,750
Trade Setup:
Entry Zone: ₹1,820–1,835 (post-breakout retest opportunity)
Stop Loss: ₹1,750 (below the right shoulder to avoid false breaks)
Why This Works?
✅ Pure Price Action Focus: The analysis relies solely on pattern structure, volume, and key levels—no indicators cluttering the chart.
✅ Volume Confirmation: Breakout supported by above average volume, reinforcing bullish momentum.
✅ Pattern Perfection: Classic Inverted H&S structure with well-defined neckline and symmetry.
✅ Breakout Conviction: Price closed decisively above ₹1,820, indicating strong follow-through.
For Indicator Users:
Traders who incorporate tools like RSI or Moving Averages can cross-verify this setup with their preferred strategies. For instance, the breakout aligns with bullish momentum on higher timeframes.
Risk Management:
Trail stops to lock profits as price approaches ₹1,910.
Partial profit booking at ₹1,910 (T1) recommended.
Conclusion:
Sun Pharma’s breakout above ₹1,820 opens the door for a rally toward its ATH. Pure price action traders can leverage the clean setup, while others may combine it with their preferred indicators. Focus on the neckline (₹1,820–1,835) for potential entries, and maintain strict risk management.
*This analysis is for educational purposes only and does not constitute financial advice, investment recommendation, or an offer to buy/sell securities. Trading involves substantial risk of loss, and past performance is not indicative of future results.
SUNPHARMA trade ideas
Sun Pharma's Inverse Head and Shoulders: Bullish Setup Ahead!Hello Traders! Today, we’re taking a look at Sun Pharmaceutical and a potential Inverse Head and Shoulders pattern that's setting up on the chart. This pattern is a classic bullish reversal setup that indicates the stock could be gearing up for an upward move, especially if the neckline breakout gets confirmed. The price has already formed the left shoulder , the head , and now we’re watching the right shoulder develop.
Once the neckline breakout happens, we’ll have a solid confirmation of the bullish move. This would give us an opportunity for fresh entries, while those already in the trade can hold their positions with a trailing stop loss . A piercing line candlestick pattern is also forming, showing increased buying interest at the right shoulder , adding more confidence to this setup.
For the entry, keep an eye on the range around 1730-1713 , with a stop loss set at 1684 to protect from unexpected moves. The targets for this trade are 1748 for short-term gains, 1792 for medium-term moves, and the final long-term target of 1587 . If this pattern confirms, we could see a nice rally in Sun Pharma . Let’s stay sharp and manage risk effectively as we watch this pattern unfold!
Disclaimer:- This analysis is for educational purposes only. Please trade responsibly and consult a financial advisor before making any decisions.
If you found this analysis helpful, don’t forget to like, follow, and share your thoughts in the comments below! Your support keeps me motivated to share more insights. Let’s grow and learn together—happy trading!
SUNPHARMA Trading Within Weekly Demand ZoneSUNPHARMA is currently trading at ₹1575.4, within the weekly demand zone ranging from ₹1596.6 (baseHigh) to ₹1565.15 (baseLow), identified on 26th July 2024. This zone may act as a key support level, potentially attracting buyers. Investors should observe price action for signs of support holding or a potential reversal before making trading decisions.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Please perform your own due diligence or consult a financial advisor before making any investment or trading decisions.
Sunpharma set up move up another 80-100 point soonSunpharma looks highly bullish with three major technical logic.
its trading above the price with highest volume transaction
its reverse from the fib retracement support
before making the big bullish candle there was a insider bar.
Sl would be around 1700 with target 1900-1950
REVENUE RICH - SUN PHARMA LTD Sun Pharma Ltd is a leading pharmaceutical company revenue rich company and strong market presence. It is one of the top beneficiaries of various incentive schemes, which have bolstered its growth and profitability.
Technical Analysis : The stock is currently forming a continuation pattern in 2 Hour Time Frame, indicating potential for further upward movement.
Entry Point: ₹1830
Stop Loss: ₹1760
Target: Open/Mentioned
Thanks, follow for more stocks recommendation.
Long The stock is approximately 56.9% undervalued relative to its intrinsic value of 4,137.50, suggesting a significant buying opportunity at the current price of 1,783.
Based on technical analysis and market trends, a correction to around 1,600 to 1,400 could be an ideal buy zone, offering even greater upside potential for investors looking to enter at a discounted price. However, starting to accumulate shares at 1,783 could still provide a strong entry point for those with a long-term horizon
Amid HMVP Virus Concerns - SUN PHARMA Trade IdeaTrade Idea Explanation:
The emergence of the HMVP virus in India has created a surge in demand for pharmaceutical products, particularly antiviral medications. Sun Pharmaceuticals, as one of India's largest and most diversified pharmaceutical companies, is well-positioned to benefit from this heightened demand. This technical trade idea aligns with the potential bullish sentiment driven by the company's fundamentals and the technical setup visible on the chart.
Technical Setup:
Rounding Bottom Pattern:
A classic reversal pattern indicating accumulation and a potential trend reversal.
The breakout from this pattern suggests a bullish continuation.
Demand Zone:
The price has shown a strong rebound from the demand zone at ₹1,840–₹1,850, reflecting significant buying interest.
Sellers' Liquidity Zone:
The price is approaching the sellers' liquidity zone near ₹1,920. A breakout above this level would indicate strength and open the door for higher targets.
Volume Confirmation:
The increasing volume at key levels validates the breakout and strengthens the bullish case.
Trade Plan:
Entry Levels:
Enter long near ₹1,850.
Alternatively, wait for a breakout above ₹1,860 for added confirmation.
Targets:
Target 1: ₹1,920 (sellers' liquidity zone).
Target 2: ₹1,960 (next major resistance zone).
Stop-Loss:
Place a stop-loss below ₹1,820 to protect against downside risk.
Risk-Reward Ratio:
Minimum 1:2, ensuring an optimal risk-to-reward setup.
Why SUN PHARMA?
Sun Pharma has a well-diversified portfolio, including antivirals and other life-saving drugs.
The HMVP virus outbreak could act as a catalyst for increased demand for its products.
The technical setup aligns with a broader market opportunity, offering a strong risk-reward proposition for mid-term traders.
Key Notes:
Monitor news related to the HMVP virus and its impact on the pharmaceutical sector.
Keep an eye on broader market sentiment and volume activity to validate the trade setup.
Adjust targets and stop-loss levels if market conditions change.
#SUNPHARMA Stock Short term Swing#SUNPHARMA Stock Short term Swing
#SUNPHARMA Stock getting ready for next bull run.
Consolidated near demand zone for the last 6 weeks and finally given a breakout last week.
ABCD activates above 1960 for the targets of 2255/2305.
Buy range is 1820-1850. SL is 1770. Targets are 2055/2105/2255.
Blue Chip Pharma: Fibo, Bullish Pattern and a good story...Pharma sector is one of the resilient sector in current market condition.
1. After fall for almost couple of months, its showing reversal signs. Made a double bottom at 38% of fib level.
2. After double bottom formation, consolidating sideways, even when Nifty was falling. This shows interest of big players and there accumulation.
3. Today, it has broken out of this sideways zone with higher volume and has confirmed the breakout.
4. Entry: 1841; SL: 1782 (3%); Target:1960 and then trailing profit with 9 EMA on day TF.
Disclaimer: I have open cash position at this counter.
SUNPHARMA - BREAKOUT RETEST or END of 5th?SUNPHARMA - CMP 1747
It appears that a 5 wave impulse from Covid lows (312) has ended at 1960
Primary and internal counts are marked in the chart
If it is too early to predict/expect a larger retracement of the entire move, lets take one step at a time and look for the price action from May'23 lows.. The 5 wave impulse from 922 to 1960. Even here, the 5 waves are complete and the price is falling/retracing.
Chart is attached here for reference
If we expect a minimum of 50% retracement of this 5 wave impulse, then we are looking at 1440 levels
Worst case, if you look at breakout retest (for those with bullish bias), then a dip down to 1640 cant be ruled out
Price is trading below the cloud and Super trend on Daily TF
Price is trading below all key EMAs.. and 200 EMA is next, placed at 1650 levels.
Definitely not a place to go long..
Daily close above 1800 would be the invalidation level
I am not a SEBI registered Analyst. Views are personal and for educational purpose only. Please consult your Financial Advisor for any investment decisions.